INFLECTRA FDA approval date

The FDA approved INFLECTRA on 5 Apr 2016.

FDA approval date
5 Apr 2016

Drug identity has not yet been verified against registry records

Also recorded as INFLIXIMAB-DYYB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-04-05DayINFLECTRAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125544", "applicant_as_listed_by_fda": "CELLTRION INC", "brand_names": ["INFLECTRA"], "active_ingredients": ["INFLIXIMAB-DYYB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160405", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026